Thursday, October 29, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Markets

Market: Pharma contract manufacturing to grow at 13.3% CAGR

Fiinews by Fiinews
October 20, 2022
in Markets
Reading Time: 2 mins read
A A
0
Aurobindo
0
SHARES
12
VIEWS
LinkedinShare on Twitter

Manufacturing edge: 58 companies are certified by US FDA, WHO, MCC and MHRA

The Indian pharmaceutical contract manufacturing market is anticipated to grow at a favourable CAGR of around 13.3% during 2022-28, as India, being one of the free trade agreement members, holds the access to the best established and emerging pharmaceutical markets in the Asia-Pacific region.

Due to the favorable factors, such as low manufacturing cost, easy availability of skilled workers, and well-established certified plants, the Indian pharmaceutical contract manufacturing has witnessed higher growth, said the report “Indian Pharmaceutical Contract Manufacturing Market Research and Forecast 2022-2028”.

Nearly 58 companies have certification including Emcure Pharmaceuticals Ltd which is certified with US FDA, WHO, Medical Control Council (MCC) and the Medicine and Healthcare products Regulatory Authority of the United Kingdom, according to the report released on 19 Oct 2022.

In basic manufacturing of medical drugs and devices, India has a superior edge over nations, such as Vietnam, China and Ireland, owing to the availability of immense raw material, technical workforce and WHO-approved production premises.

During the COVID-19 pandemic, several initiatives were taken by the Union Cabinet to boost the Indian pharmaceutical industry, which includes the amendment of the existing foreign direct investment (FDI), which allows the foreign investors to invest up to 100% under the automatic route for manufacturing medical devices.

With the advent of global pharmaceutical organizations, and their vast presence in India, the concept of contract manufacturing has steadily evolved, which in turn boosts the growth of India’s pharmaceutical contract manufacturing market, said the report.

Leading companies in the sector are:

Agrata Biotech Ltd

Ankur Drugs and Pharma Ltd

Aurobindo Pharma

BDR Pharmaceuticals Internationals Pvt Ltd

Ceegolabs Pvt Ltd

Ciron Drugs & Pharmaceuticals Pvt Ltd

Contract Pharmaceuticals Ltd

Cosway Biosciences

Cubic Lifesciences Pvt Ltd

Daffohils Laboratories Pvt Ltd. fiinews.com

Tags: ResearchAndMarkets
ShareTweetShare

Related Posts

PIB
Markets

Market: India sourced energy guided by national interests

by Fiinews
October 29, 2026
0
18

Puri focused on strengthening the country’s long-term energy resilience India’s energy sourcing decisions were guided by its national interests and...

Coforge
Markets

Market: Coforge wins 8 large deals in Q2

by Fiinews
October 25, 2026
0
30

Singh says his group aims to be amongst top three scaled IT services firms Coforge Limited (NSE: COFORGE), a global...

Skoda

Market: Berlin talks included partnership expansions

October 25, 2026
16
Infosys

Market: Infosys delivers strong revenues in Q2

October 25, 2026
23
Namaste Bharat 2026.

Market: Women entrepreneurs seek businesses in SG

October 25, 2026
23
Sauce Labs Logo

Market: Sauce Labs expands to India

October 24, 2026
19
SBI YONO

POPULAR NEWS

  • Wipro emerges leader in Everest’s MatrixTM 2018

    0 shares
    Share 0 Tweet 0
  • Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: PM Modi-President Zelenskyy discussed trade and technology

    0 shares
    Share 0 Tweet 0
  • Investment: India welcomes US investment and technology collaboration

    0 shares
    Share 0 Tweet 0
  • Manufacturing: Approved ‘BioE3’of Biotechnology Dept

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Invest: AssetMark expands presence in India with GCC
  • Invest: Prince Alois updated on economic progress
  • Export: India-Mexico sign PTA Terms of Reference
  • Manufacture: Textile PLI reopened for applications
  • Tender: JWG to work on Thoothukudi shipyard

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.